#CancerDx
In #CancerDx news, Natera's $NTRA Oncology test volumes rise up considerably in 2024. Signatera's growth outpacing early trailblazers like Foundation Medicine
January 9, 2025 at 6:47 AM
An assortment of #NGS and #Multiomics news, both basic and #Applied in #CancerDx and other fields
albertvilella.substack.com/p/ngsx-news-...
July 6, 2026 at 10:22 AM
Freenome has updated the performance metrics for the v2 of their SimpleScreen #CRC assay. But what does it mean for the field of #LiquidBiopsy #NGS #CancerDx ? open.substack.com/pub/albertvi...
Freenome's updated sensitivity values for their SimpleScreen CRC assay
Updated test version achieved significant performance improvement in detecting advanced precancerous lesions, including those with high-grade dysplasia
open.substack.com
July 10, 2026 at 8:49 AM
Sharper CTC classification ⇒ fewer misses ✦ Dual-branch deep net pairs morphology + context • Worth a look? ➜ https://glcnd.io/enhanced-classification-of-circulating-tumor-cells-using-a-dual-branch-deep-learning-network/ #CTC #DeepLearning #CancerDx
Enhanced Classification of Circulating Tumor Cells Using a Dual-Branch Deep Learning Network - GLCND.IO
glcnd.io
September 28, 2025 at 2:22 PM
## Hyperdimensional Biomarker Correlation Analysis for Early-Stage Lung Cancer Detection via Exhaled Volatile Organic Compounds (EVOCs)

**Abstract:** Early-stage lung cancer detection remains a significant challenge, relying heavily on invasive biopsies and often presenting with vague symptoms.…
## Hyperdimensional Biomarker Correlation Analysis for Early-Stage Lung Cancer Detection via Exhaled Volatile Organic Compounds (EVOCs)
**Abstract:** Early-stage lung cancer detection remains a significant challenge, relying heavily on invasive biopsies and often presenting with vague symptoms. This paper proposes a novel analytical framework leveraging hyperdimensional computing (HDC) and machine learning for non-invasive lung cancer detection via analysis of Exhaled Volatile Organic Compounds (EVOCs). The method, termed HV-CancerDx, transforms complex EVOC profiles into high-dimensional hypervectors, enabling the identification of subtle biomarker correlations undetectable by conventional analytical techniques.
freederia.com
January 4, 2026 at 12:04 PM
Emerging Biomarkers like ctDNA Revolutionize Early Cancer Detection. ctDNA outperforms traditional markers like CA 19-9 for prognostication in advanced pancreatic cancer and enables detection years before clinical diagnosis in HPV-related cancers. Pathologists should ...

#Pathology #CancerDx #MedEd
May 3, 2026 at 4:03 AM
AI is transforming acute leukemia diagnosis. A new review shows machine learning can enhance morphological analysis, improving accuracy and speed in identifying leukemia subtypes—critical for timely treatment decisions.

#Oncology #CancerDx #MedEd
May 3, 2026 at 3:31 AM
🔍 Missed cancer-diagnosis claims can surface 5 years later—will your policy protect or pay?

Discover the top litigated cancers, follow-up traps & the rider that shields past care in a 5-min read.
👉 www.getindigo.com/blog/cancer-...

#MedMal #RiskManagement #CancerDx #IndigoInsurance
Does Your Malpractice Insurance Cover Cancer Misdiagnosis?
Read about how medical malpractice insurance covers cancer misdiagnosis claims, common causes, legal risks & steps to protect your practice & patients.
www.getindigo.com
May 12, 2025 at 5:15 PM